Allergan CEO sits down with Mad Money's Jim Cramer

Posted in Biotech

May 01, 2018 • 3 min read

Allergan CEO, Brent Saunders, was on Mad Money with Jim Cramer last night to discuss Allergan earnings and their pipeline, specifically, Rapastinel, a potentially game changing depression drug. ...

Hep C and Humira lead AbbVie's Q1 revenue growth

Posted in Biotech

April 26, 2018 • 4 min read

AbbVie posted better than expected Q1 earnings this morning, led by HUMIRA, IMBRUVICA and their Hepatitis C franchise. Total worldwide revenue was $7.934 billion, helping AbbVie achieve YOY growth of 17.4% in the quarter. AbbVie's heavily weighted revenue from HUMIRA is concerning and yet impressive, considering 2/3 of the companies revenue comes from the product. Where the concern lessens is from the continued growth in HCV, where their franchise exploded to $919 million in revenue, easily o...

Abbott's FreeStyle Libre is adding 50k users per month

Posted in Biotech

April 25, 2018

Can Instagram Be MannKind Afrezza's Best Marketing Tool?

Posted in Biotech

December 05, 2017 • 3 min read

Can Instagram be the pharmaceutical industry's new best friend? This post is by no means a case study, but there are certain sets of patients who actively seek out better treatment options, and patients with Diabetes are at the top of this unscientific...